Cocrystal Pharma, Inc.
corporate_fare Company Profile
Cocrystal Pharma, Inc. (NASDAQ:COCP) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for COCP at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Cocrystal Pharma Announces Passing of Board Director Dr. Anthony Japour
- Cocrystal Pharma Doses First Subjects in Phase 1b Norovirus Study for CDI-988
- Cocrystal Pharma to Present Phase 1 Norovirus Antiviral Data at ICAR 2026
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$8.83M
Diluted EPS
-$0.78
Op. Cash Flow
-$8.19M
Free Cash Flow
-$8.2M
Operating Income
-$9.02M
Cash & Equivalents
$7.03M
Debt / Equity
0.00×
Shares Outstanding
13.78M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-013838
show_chartPrice Chart
Loading chart...
feed COCP - Filings & News (Page 2)
COCP
Mar 13, 2026, 4:30 PM EDT
Price at Filing:
$1.03
Real-time Price:
$0.990
Change:
-$0.040 (-4%)
Market Cap:
$18.302M
COCP
Mar 09, 2026, 8:30 AM EDT
Price at Filing:
$1.06
Real-time Price:
$0.990
Change:
-$0.070 (-7%)
Market Cap:
$18.302M
COCP
Feb 19, 2026, 8:30 AM EST
Price at Filing:
$0.9799
Real-time Price:
$0.990
Change:
+$0.0101 (+1%)
Market Cap:
$18.302M